Loading...

MALLINCKRODT PLC Management Changes 8-K Filing

MLLN

MALLINCKRODT PLC

()

2026 8-K

Financial Results Update

CEO Employment Agreement

Stock Incentive Plan

Spin-off Details

Financial Results Report

Fiscal Year Change

Financial Statement Disclosure

Spin-off Announcement

Mallinckrodt Acquisition

Preferred Shares Issued

Shareholder Meeting Results

Financial Disclosure

Management Change

Management Change

Stock Incentive Plan

Asset Acquisitions

Asset Acquisitions

Merger of Equals

Merger of Equals

Merger of Equals

Merger of Equals

Compensatory Arrangements o...

Financial Statements

Transaction Agreement

Merger Agreement

Merger Agreement

Financial Results

External Links:

On February 23, 2026, Keenova Therapeutics plc announced that Sigurdur Olafsson has signed a new employment agreement as CEO, effective until January 1, 2028, with an annual salary of $1.2 million and potential bonuses of up to 400%. This is a significant development for the company.

AI Assistant

MALLINCKRODT PLC

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.